Clovis Oncology to Announce First Quarter 2017 Financial Results and Host Webcast Conference Call on May 3
April 20 2017 - 08:00AM
Business Wire
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first
quarter 2017 financial results on Wednesday, May 3, 2017, after the
close of the U.S. financial markets. Clovis’ senior management will
host a conference call and live audio webcast at 4:30 p.m. ET that
day to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from
the Clovis Oncology website at www.clovisoncology.com. A replay of
the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss first quarter 2017
results on May 3, at 4:30 p.m. ET. The conference call will be
simultaneously webcast on the Company’s website at
www.clovisoncology.com, and archived for future review. Dial-in
numbers for the conference call are as follows: US participants
866.489.9022, International participants 678.509.7575, conference
ID: 11635860.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools that direct a compound in development to the
population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado, and has additional
offices in San Francisco, California and Cambridge,
UK.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170420005398/en/
Clovis Oncology, Inc.Breanna Burkart,
303-625-5023bburkart@clovisoncology.comorAnna Sussman,
303-625-5022asussman@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2023 to Mar 2024